Harvard The Comprehensive 2022 Gastroenterology Update
58 Mp4 Video + 41 PDF , Course Size = 4.09 GB
Habebis TRACTUS VIA AEVUM DOWNLOAD LINK (FAST SPEED) post solutionem
Haec progressio efficit participes participes e statu-of-arte GI strategies et exercitia clinica. Recentes progressiones eorumque impulsum in accessibus clinicis et patientibus eventibus contegit. Renovationes, optimae consuetudines, novaque admonitiones exhibentur a peritis et magistris clinicianis nationalibus agnitis GI.
Practical, Results-Coegi Educationis
Programma elucidat MMXXI:
- Renovata guidelines ad usum biologicorum in IBD
- Therapeutic medicamento magna in IBD curatio
- Updated guidelines curatio est C. perfringens infectione
- Complicationes GI administrandi immunotherapy
- Procuratio emendata IBS et pelvis area perturbationes
- Procuratio refractoriae GERD
- Expanded geneticae probationis optiones ad egritudinem syndromes cancer hereditarius GI
- Management iecoris pingue morbum in 2022
- Exercitia optima ad curatio HCV
- Quam ut amplio vestri rate deprehensio adenoma (ADR)
- Ad curare partum est summus qualis cura colonoscopic
- Artes efficaciter moderari sanguinem GI acutis
- Cum FMT indicatur ad curatio
- Impulsum COVID in GI usu
- Nova consilia communes GI difficultates tractandi
- A comprehensive update guidelines nationalis
Cum nova consilia, guidelines, et optiones diagnostica et curationes exhibentur, cum certis commendationibus coniunguntur his updates in opus hodiernum tuum incorporandi.
Educationem ad Optimize tuum patientiam eventus
Probationes substructio commendationes in hoc programma operculum praebebant:
- IBD
- GI Complicationes de Immunotherapy
- Microscopic Colitis
- Hepatitis C
- pingue Jecur
- Barrett's Esophagus
- Eosinophilic Esophagitis
- C. perfringens colitis
- Sin-Related iecoris Morbus
- Hepatitis autoimmune
- IBS
- Refractory GERD
- Intrapelvicorum Solum Disorders
- Acuti pancreatitis
- longos Pancreatitis
- coeliacis morbo
- GI Bleeding
- High Risk for Colorectal Cancer
- Perturbationes nutritionales ad GI Conditiones pertinentes
Recent Acta et Innovationes
Clinici in hoc programmate educationis confidere possunt:
- Therapiae biologicae pro IBD: quomodo eligere quod agens committitur cum? Quomodo monitor in curatione? Quae est munus medicamenti medendi vigilantia? Ubi vertas? Quid novi agentes nunc praesto sunt?
- Administrandi repugnantia pouchitis
- GI complicationes immunotherapiae - inordinatio communis et heterogenea: quomodo accedere et tractare efficaciter?
- Therapiae antivirales pro hepatitis C: quomodo seligere qua ratione utatur? Intelligere longum tempus metus justo
- Oesophagitis eosinophilicus: quomodo iudicare inter pharmacum therapiam et puritatem theraphim?
- Scabellum microbiome: scientiam post applicationes clinicas intellegentiae
- Morbi coeliaci: sensus multiplex testium serologicorum faciens – consilia nova therapeutica in horizonte sunt
- Adenoma deprehensio rates: critica metiri et quomodo inserere consilia ad augendam ratem tuam
Haec programmata etiam conspectum praebet in futurum gastroenterologiae cum praelectionibus habitis a peritis mundi celeberrimis inspirandis et incisis argumentis.
Et Theodotionis Topics:
Monday, June 13, 2022
8:30am ut 8:35am | WelcomeDaniel Chung, MD | |
8:35am ut 9:20am | Quod Coepi Therapy eligere ad Crohn scriptor ac UC? Joshua Korzenik, MD | |
9:20am ut 10:00am | Procuratio Severi UC et Pouch-Related ComplicationesAshwin Ananthakrishnan, MD, MPH | |
10:00am ut 10:40am | IBD in Special Populations: Graviditas et Senex Friedman, MD | |
10:40am ut 10:55am | Panel Q&AAshwin Ananthakrishnan, MD, MPH; Sonia Friedman, MD; Josue Korzenik, MD | |
10:55am ut 11:10am | gaudete | |
11:10am ut 11:45am | OFFICINA I: Dermatologicae Manifestationes IBDDaniela Kroshinsky, MD | |
11:45am ut 12: 25pm | Medicamentum Therapeuticum Monitoring in IBDAdam Cheifetz, MD | |
12: 25pm ut 12: 40pm | Panel Q&AAdam Cheifetz, MD; Daniela Kroshinsky, MD | |
12: 40pm ut 1: 40pm | gaudete | |
1: 40pm ut 2: 15pm | Quomodo Curo Microscopic ColitisHamed Khalili, MD? | |
2: 15pm ut 2: 50pm | GI Complicationes de ImmunotherapyMichael Dougan, MD, PhD | |
2: 50pm ut 3: 05pm | Panel Q&AMIchael Dougan, MD, PhD; Hamed Khalili, MD | |
3: 05pm ut 3: 20pm | gaudete | |
3: 20pm ut 3: 55pm | What's New in Hereditary GI CancersDaniel Chung, MD | |
3: 55pm ut 4: 30pm | OFFICINA 2: CRC Screening and How to improve Your ADRRamona Lim, MD | |
4: 30pm ut 5: 05pm | Chemoprevention of CRC: Quid Commendas? Andrew Chan, MD, MPH | |
5: 05pm ut 5: 20pm | Panel Q&AAndrew Chan, MD, MPH; Daniel Chung, MD; Ramona Lim, MD |
8:30am ut 9:05am | Barrett esophagi: quem et quomodo tractare? Douglas Pleskow, MD | |
9:05am ut 9:40am | Motility Disorders Esophageal Made EasyBarbara Nath, MD | |
9:40am ut 10:15am | Procuratio Refractionis GERDNorman Nishioka, MD | |
10:15am ut 10:30am | Panel Q&ABarbara Nath, MD; Normal Nishioka, MD; Douglas Pleskow, MD | |
10:30am ut 10:45am | gaudete | |
10:45am ut 11:20am | Comprehensive Accedere ad Eosinophilic EsophagitisWalter Chan, MD | |
11:20am ut 12: 10pm | Morbus coeliac et Sensitivity gluten: 2022 Practitioner UpdatesCiaran Kelly, MD | |
12: 10pm ut 12: 25pm | Panel Q&AWalter Chan, MD; Ciaran Kelly, MD | |
12: 25pm ut 1: 30pm | gaudete | |
1: 30pm ut 2: 10pm | Optimizing Management GastroparesisBraden Kuo, MD | |
2: 10pm ut 2: 50pm | Faciens Diagnosis IBSKyle Staller, MD | |
2: 50pm ut 3: 30pm | IBSAnthony Lembo, MD | |
3: 30pm ut 3: 45pm | Panel Q&ABraden Kuo, MD; Antonius Lembo, MD; Kyle Staller, MD; | |
3: 45pm ut 4: 00pm | gaudete | |
4: 00pm ut 4: 30pm | How to Evaluate Small Intestinal Bacterial OvergrowthJudy Nee, MD? | |
4: 30pm ut 5: 00pm | OFFICINA III: Systematica Accessus ad Tabulatum intrapelvicorum DisordersMeghan Markowski, PT, DPT | |
5: 00pm ut 5: 15pm | Panel Q&AMeghan Markowski, PT, DPT; Judy Nec, MD |
8:30am ut 9:05am | Hepatitis C ad EradicationRaymond Chung, MD | |
9:05am ut 9:45am | De Morbis cholestaticae iecuris: Quid in PBC et PSCDaniel Pratt, MD? | |
9:45am ut 10:15am | Renova in Autoimmune HepatitisAlan Bonder, MD | |
10:15am ut 10:30am | Panel Q&AAlan Bonder, MD; Raymond Chung, MD; Daniel Pratt, MD | |
10:30am ut 10:45am | gaudete | |
10:45am ut 11:25am | Alcoholicum jecoris DiseaseGyongyi Szabo, MD, PhD | |
11:25am ut 12: 00pm | De pestilentia NAFLDKathleen Corey, MD | |
12: 00pm ut 12: 15pm | Panel Q&AKathleen Corey, MD; Gyongyi Szabo, MD | |
12: 15pm ut 1: 15pm | gaudete | |
1: 15pm ut 1: 50pm | OFFICINA 4: Quomodo laborare Jecur NoduleKarin Andersson, MD | |
1: 50pm ut 2: 25pm | OFFICINA 5: Quomodo accedere medicamentis Iniuriam iecoris inductam (DILI) Michael Curry, MD | |
2: 25pm ut 3: 05pm | Finis-Stage Liver Disease and Management of Portal HypertensionAnna Rutherford, MD | |
3: 05pm ut 3: 20pm | Panel Q&AKarin Andersson, MD; Michael Curry, MD; Anna Rutherford, MD | |
3: 20pm ut 3: 30pm | gaudete | |
3: 30pm ut 4: 05pm | Best Management Strategies in Acuti PancreatitisDavid X Jin, MD, MPH | |
4: 05pm ut 4: 40pm | Renovationes in Chronico PancreatitisSunil Seth, MD | |
4: 40pm ut 5: 15pm | Controversiae in administratione Lesionum cysticorum de PancreasCarlos Fernandez, MD | |
5: 15pm ut 5: 30pm | Panel Q&ACarlos Fernandez, MD; David X Jin, MD, MPH; Sunil Seth, MD |
8:30am ut 9:15am | OFFICINA 6: Tips ad removendum difficilem PolypTyler Berzin, MD | |
9:15am ut 9:45am | Quality Mensurae pro Colonoscopia: Quid Novi et Cur MattersMandeep Sawhney, MD | |
9:45am ut 10:00am | Panel Q&ATyler Berzin, MD; Mandeep Sawhney, MD | |
10:00am ut 10:15am | gaudete | |
10:15am ut 10:45am | Insights novae in Gut Microbiome et DiseaseRamnik Xaverii, MD | |
10:45am ut 11:25am | COVID in the GI TractWalter Chan, MD | |
11:25am ut 12: 05pm | What's New in C. difficile ColitisJessica Allegretti, MD, MPH | |
12: 05pm ut 12: 20pm | Panel Q&AWalter Chan, MD; Ramnik Xaverius, MD | |
12: 20pm ut 1: 20pm | gaudete | |
1: 20pm ut 2: 00pm | Endoscopia et Anticoagulata PatientKunal Jajoo, MD | |
2: 00pm ut 2: 40pm | Acute GI Bleeding and Other GI EmergenciesLinda Lee, MD | |
2: 40pm ut 2: 55pm | Panel Q&AJessica Allegretti, MD, MPH; Kunal Jajoo, MD; Linda Lee, MD | |
2: 55pm ut 3: 10pm | gaudete | |
3: 10pm ut 3: 50pm | OFFICINA 7: Causae provocantes in GIDouglas Horst, MD | |
3: 50pm ut 4: 30pm | GI Management Obesity et Metabolicae DisordersLee Kaplan, MD, PhD | |
4: 30pm ut 5: 05pm | Improving Nutritional Management in GI DiseaseAndrew Ukleja, MD | |
5: 05pm ut 5: 20pm | Panel Q&ADouglas Horst, MD; Lee Kaplan, MD, PhD; Andreas Ukleja, MD |
Published: June VIII - XII, MMXX